# Hydrogen In Neonatal Encephalopathy (HIE) Trial

> **NCT07411911** · PHASE1 · NOT_YET_RECRUITING · sponsor: **Boston Children's Hospital** · enrollment: 54 (estimated)

## Conditions studied

- HIE
- Hypoxic-Ischemic Encephalopathy

## Interventions

- **DRUG:** Hydrogen Gas (H2)

## Key facts

- **NCT ID:** NCT07411911
- **Lead sponsor:** Boston Children's Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-03
- **Primary completion:** 2028-03
- **Final completion:** 2031-03
- **Target enrollment:** 54 (ESTIMATED)
- **Last updated:** 2026-02-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07411911

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07411911, "Hydrogen In Neonatal Encephalopathy (HIE) Trial". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT07411911. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*